Overview

This trial is active, not recruiting.

Condition acute decompensated heart failure
Sponsor Byung-Hee Oh
Collaborator National Institute of Health, Korea
Start date March 2011
End date December 2018
Trial size 5625 participants
Trial identifier NCT01389843, H-1102-072-352

Summary

KorAHF is a multi-center registry (prospective cohort) for acute decompensated heart failure patients in Korea.

The aim of this registry is to analyze several causes affecting prognosis and survival and to develop new strategies for managing acute decompensated heart failure.

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Observational model cohort
Time perspective prospective
Arm
All consecutive hospitalized adult patients who have 1 and (2 and/or 3) Symptom and/or sign of heart failure Lung congestion Objective finding of LV systolic dysfunction (LVEF), or structural heart disease.

Primary Outcomes

Measure
Mortality and Re-hospitalization of acute decompensated heart failure
time frame: 5 years (tentative)

Eligibility Criteria

Male or female participants of any age.

Inclusion Criteria: All consecutive hospitalized adult patients who have 1 and (2 and/or 3) 1. Symptom and/or sign of heart failure 2. Lung congestion 3. Objective finding of LV systolic dysfunction (LVEF), or structural heart disease Exclusion Criteria: - N.C.

Additional Information

Official title Registry (Prospective Cohort) for Heart Failure in Korea (KorAHF)
Principal investigator Byung-Hee Oh, MD, PhD
Trial information was received from ClinicalTrials.gov and was last updated in April 2016.
Information provided to ClinicalTrials.gov by Seoul National University Hospital.